According to a study conducted by Jin et al., FGF14-AS2 functions as a competitive endogenous RNA (ceRNA) of miR-370-3p, thereby promoting the expression of FGF14 at the post-transcriptional level in breast cancer [53]. The gene discussed is FGF14; the disease is breast carcinoma.